H&SCAP LIMITED

Company number 13196764 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

H&SCAP LIMITED - Analysis Report

Company Number: 13196764

Analysis Date: 2025-07-19 12:12 UTC

Financial Health Assessment Report for H&SCAP LIMITED


1. Financial Health Score: D

Explanation:
The company exhibits clear signs of financial strain, particularly with a negative net asset position and significant current liabilities exceeding current assets. While the company holds valuable fixed assets, the heavy short-term liabilities and negative working capital suggest liquidity challenges and potential difficulties meeting immediate obligations.


2. Key Vital Signs:

Metric Value (2024) Interpretation
Fixed Assets £185,300 Indicates substantial investment in long-term assets, likely property or real estate holdings.
Current Assets £1,592 Very low short-term liquid assets, insufficient to cover short-term obligations.
Current Liabilities £124,985 High short-term debts, a warning sign of liquidity stress.
Net Current Assets (Working Capital) -£60,373 Negative working capital, indicating inability to cover current liabilities with current assets.
Creditors Due After One Year £124,985 Large long-term liabilities, possibly mortgage or loans secured against property assets.
Net Assets -£360 Negative net equity reflects liabilities exceeding total assets, a symptom of financial distress.
Share Capital £1.00 Minimal paid-up capital, typical for micro-entity but offers little buffer for financial shocks.

3. Diagnosis:

H&SCAP LIMITED’s financial “vital signs” reveal a company in a fragile state. The substantial fixed assets suggest the company primarily operates in property-related activities (confirmed by SIC codes 68100 and 68209), possibly owning or leasing real estate. However, the "symptoms" of distress are evident in the liquidity measures:

  • The negative working capital (-£60,373) is a critical red flag. It means that the company does not have enough short-term resources to cover its immediate debts, potentially leading to cash flow problems.
  • The negative net assets (-£360), although small, imply that liabilities slightly exceed assets. This could be due to accumulated losses or high leverage.
  • The company’s current liabilities (£124,985) are overwhelmingly greater than its current assets (£1,592), signaling an urgent mismatch between incoming cash and obligations due.
  • The balance between fixed assets (£185,300) and long-term creditors (£124,985) suggests the company has financed its property assets heavily through debt, which in itself is not unusual in real estate but increases financial risk if rental income or asset values decline.
  • Lack of employees may suggest a lean operation, possibly asset holding without active trading.

In medical terms, H&SCAP LIMITED’s "heart" (long-term asset base) is strong, but its "circulatory system" (cash flow and liquidity) shows signs of blockage and strain, which could lead to operational difficulties if not addressed.


4. Recommendations:

  1. Improve Liquidity:

    • Seek to increase current assets, especially cash or receivables, to improve working capital. This may involve negotiating payment terms with creditors or accelerating collection of any receivables.
    • Explore short-term financing options to cover immediate liabilities and avoid default.
  2. Debt Restructuring:

    • Review the terms of long-term creditors (£124,985) to assess possibilities for extending repayment periods or refinancing to reduce short-term pressure.
    • Consider discussions with lenders about restructuring debt to improve cash flow.
  3. Asset Utilization:

    • Evaluate the fixed assets to confirm their market value and potential to generate income (e.g., rental income). If underutilized, consider monetizing part of these assets to bolster cash reserves.
  4. Financial Monitoring:

    • Implement a robust cash flow forecasting process to detect and manage liquidity risks early.
    • Regularly monitor key metrics like working capital and current ratio to maintain financial “vital signs” within healthy ranges.
  5. Capital Injection:

    • Consider raising equity capital to provide additional financial buffer and reduce reliance on debt.
  6. Strategic Business Review:

    • Assess the company’s business model and revenue streams to ensure sustainable income generation matching financial obligations.

Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 19 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.